trending Market Intelligence /marketintelligence/en/news-insights/trending/yrP0LzBQV2LI4B9DiwYwVQ2 content esgSubNav
In This List

Sanofi execs, Philippine officials face criminal charges over Dengvaxia


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Sanofi execs, Philippine officials face criminal charges over Dengvaxia

The former president of Philippines Benigno Aquino III and former government officials, as well as Sanofi executives, are facing charges relating to a vaccination program involving Sanofi's dengue vaccine Dengvaxia, CNN Philippines reported.

The news agency stated that more than 70 mothers with children who were vaccinated filed for criminal prosecution and asked the high court to force the departments of health, education, and interior and local government to provide long-term consultations and treatment for children who received the vaccine in 2016.

Apart from Aquino, charges were also placed against the former department of health chief Janette Garin, two other government officials, Sanofi CEO Olivier Brandicourt, Sanofi Asia-Pacific Head Thomas Triomphe and three other Sanofi executives, The Philippine Star reported.

The complaint states that the defendants must be held liable for violations of the Anti-Graft and Corrupt Practices Act.

Previously, the Philippine government launched an investigation after the French drugmaker revealed Dengvaxia could worsen the disease in people not previously infected.

Sanofi spokesperson Jack Cox said the company has not directly seen the complaint and noted that the company has acted according to Philippine laws and regulations to supply and sell the vaccine according to the approved indication, Fierce Pharma reported, citing an emailed response.

Cox said the company will work cooperatively with health authorities in the Philippines to answer any additional questions.